QIAGEN Shares Outstanding 2006-2018 | QGEN

QIAGEN shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • QIAGEN shares outstanding for the quarter ending September 30, 2018 were 0.235B, a 1.04% increase year-over-year.
  • QIAGEN 2017 shares outstanding were 0.233B, a 2.5% decline from 2016.
  • QIAGEN 2016 shares outstanding were 0.239B, a 0.14% increase from 2015.
  • QIAGEN 2015 shares outstanding were 0.239B, a 1.71% decline from 2014.
QIAGEN Annual Shares Outstanding
(Millions of Shares)
2017 233
2016 239
2015 239
2014 243
2013 233
2012 232
2011 230
2010 232
2009 206
2008 197
2007 169
2006 148
2005 145
QIAGEN Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 235
Q2 2018 234
Q1 2018 233
Q4 2017 233
Q3 2017 233
Q2 2017 233
Q1 2017 235
Q4 2016 239
Q3 2016 239
Q2 2016 239
Q1 2016 238
Q4 2015 239
Q3 2015 228
Q2 2015 228
Q1 2015 229
Q4 2014 243
Q3 2014 232
Q2 2014 232
Q1 2014 234
Q4 2013 233
Q3 2013 233
Q2 2013 225
Q1 2013 233
Q4 2012 232
Q3 2012 233
Q2 2012 231
Q1 2012 230
Q4 2011 230
Q3 2011 229
Q2 2011 232
Q1 2011 231
Q4 2010 231
Q3 2010 230
Q2 2010 233
Q1 2010 227
Q4 2009 232
Q3 2009 201
Q2 2009 196
Q1 2009 196
Q4 2008 195
Q3 2008 197
Q2 2008 198
Q1 2008 198
Q4 2007 206
Q3 2007 179
Q2 2007 151
Q1 2007 147
Q4 2006 149
Q3 2006 148
Q2 2006 148
Q1 2006 147
Q4 2005 144
Q3 2005 145
Q2 2005 144
Q1 2005 144
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $7.997B $1.418B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $125.010B 14.13
Gilead Sciences (GILD) United States $87.604B 10.55
Biogen (BIIB) United States $64.432B 13.05
Celgene (CELG) United States $48.591B 9.43
Illumina (ILMN) United States $48.348B 56.32
Vertex Pharmaceuticals (VRTX) United States $44.270B 77.33
Regeneron Pharmaceuticals (REGN) United States $40.656B 20.60
Alexion Pharmaceuticals (ALXN) United States $25.618B 17.53
BioMarin Pharmaceutical (BMRN) United States $16.442B 0.00
Incyte (INCY) United States $13.960B 385.88
Seattle Genetics (SGEN) United States $9.759B 0.00
Exact Sciences (EXAS) United States $8.544B 0.00
Sarepta Therapeutics (SRPT) United States $8.353B 0.00
BeiGene (BGNE) Cayman Islands $8.129B 0.00
Alnylam Pharmaceuticals (ALNY) United States $7.758B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.571B 48.41
Exelixis (EXEL) United States $6.273B 17.78
Bio-Techne Corp (TECH) United States $5.949B 40.19
Bluebird Bio (BLUE) United States $5.733B 0.00
Alkermes (ALKS) Ireland $5.356B 3447.00
Amarin (AMRN) Ireland $5.351B 0.00
Galapagos (GLPG) Belgium $5.260B 0.00
Guardant Health (GH) United States $3.751B 0.00
Immunomedics (IMMU) United States $3.590B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.546B 0.00
Emergent Biosolutions (EBS) United States $3.378B 28.46
Array BioPharma (ARRY) United States $3.292B 0.00
Horizon Pharma Public (HZNP) Ireland $3.279B 13.49
ARGENX SE-ADR (ARGX) Netherlands $3.217B 0.00
Allogene Therapeutics (ALLO) United States $3.157B 0.00
Ligand Pharmaceuticals (LGND) United States $3.115B 23.83
Intercept Pharmaceuticals (ICPT) United States $3.102B 0.00
Akcea Therapeutics (AKCA) United States $2.861B 0.00
Repligen (RGEN) United States $2.713B 84.74
Ascendis Pharma (ASND) Denmark $2.613B 0.00
Allakos (ALLK) United States $2.590B 0.00
Genomic Health (GHDX) United States $2.586B 87.32
Blueprint Medicines (BPMC) United States $2.512B 0.00
China Biologic Products (CBPO) China $2.474B 17.61
ACADIA Pharmaceuticals (ACAD) United States $2.323B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.312B 0.00
Myriad Genetics (MYGN) United States $2.302B 22.81
Halozyme Therapeutics (HALO) United States $2.235B 49.87
Global Blood Therapeutics (GBT) United States $2.234B 0.00
Acceleron Pharma (XLRN) United States $2.212B 0.00
MyoKardia (MYOK) United States $2.194B 0.00
Arena Pharmaceuticals (ARNA) United States $2.024B 0.00
Amicus Therapeutics (FOLD) United States $1.999B 0.00
Denali Therapeutics (DNLI) United States $1.941B 0.00
Atara Biotherapeutics (ATRA) United States $1.934B 0.00
AnaptysBio (ANAB) United States $1.918B 0.00
REGENXBIO (RGNX) United States $1.915B 25.69
CRISPR Therapeutics AG (CRSP) Switzerland $1.853B 0.00
Innoviva (INVA) United States $1.766B 9.99
Reata Pharmaceuticals (RETA) United States $1.763B 0.00
Spark Therapeutics (ONCE) United States $1.540B 0.00
Medicines (MDCO) United States $1.529B 0.00
Cambrex (CBM) United States $1.484B 11.08
Rubius Therapeutics (RUBY) United States $1.483B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.476B 0.00
WAVE Life Sciences (WVE) Singapore $1.425B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.425B 113.17
Editas Medicine (EDIT) United States $1.415B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.380B 0.00
Aimmune Therapeutics (AIMT) United States $1.364B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.332B 0.00
Mirati Therapeutics (MRTX) United States $1.309B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.308B 0.00
NeoGenomics (NEO) United States $1.290B 106.69
Myovant Sciences (MYOV) United Kingdom $1.236B 0.00
G1 THERAPEUTICS (GTHX) United States $1.233B 0.00
Lion Biotechnologies (IOVA) United States $1.222B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.206B 0.00
Insmed (INSM) United States $1.200B 0.00
Sangamo Therapeutics (SGMO) United States $1.199B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.169B 0.00
Clovis Oncology (CLVS) United States $1.132B 0.00
UniQure (QURE) Netherlands $1.071B 0.00
Fate Therapeutics (FATE) United States $1.056B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.022B 0.00
Apellis Pharmaceuticals (APLS) United States $1.009B 0.00
Retrophin (RTRX) United States $1.003B 0.00
Audentes Therapeutics (BOLD) United States $1.002B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.932B 0.00
Momenta Pharmaceuticals (MNTA) United States $0.909B 0.00
Puma Biotechnology (PBYI) United States $0.897B 0.00
Novavax (NVAX) United States $0.854B 0.00
Intra-Cellular Therapies (ITCI) United States $0.847B 0.00
Solid Biosciences (SLDB) United States $0.840B 0.00
Cellectis (CLLS) France $0.835B 0.00
DBV Technologies (DBVT) France $0.821B 0.00
Athenex (ATNX) United States $0.817B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.806B 0.00
Revance Therapeutics (RVNC) United States $0.804B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.781B 0.00
Acorda Therapeutics (ACOR) United States $0.769B 9.73
Vericel (VCEL) United States $0.761B 0.00
AC Immune SA (ACIU) Switzerland $0.761B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.752B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.751B 0.00
Heska (HSKA) United States $0.740B 60.60
Aptinyx (APTX) United States $0.732B 0.00
Gritstone Oncology (GRTS) United States $0.731B 0.00
Intellia Therapeutics (NTLA) United States $0.716B 0.00
Principia Biopharma (PRNB) United States $0.701B 0.00
InflaRx (IFRX) Germany $0.688B 0.00
Dynavax Technologies (DVAX) United States $0.678B 0.00
Scholar Rock Holding (SRRK) United States $0.678B 0.00
Viking Therapeutics (VKTX) United States $0.677B 0.00
Coherus BioSciences (CHRS) United States $0.672B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.665B 0.00
CytomX Therapeutics (CTMX) United States $0.654B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.648B 0.00
ANI Pharmaceuticals (ANIP) United States $0.646B 12.36
UROGEN PHARMA (URGN) Israel $0.626B 0.00
UNITY Biotechnology (UBX) $0.621B 0.00
Cara Therapeutics (CARA) United States $0.617B 0.00
TWIST BIOSCIENC (TWST) United States $0.612B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.609B 0.00
AVROBIO (AVRO) United States $0.589B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.548B 0.00
Arvinas (ARVN) United States $0.544B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.543B 0.00
Arcus Biosciences (RCUS) United States $0.540B 0.00
ObsEva SA (OBSV) Switzerland $0.534B 0.00
Kura Oncology (KURA) United States $0.533B 0.00
Eidos Therapeutics (EIDX) United States $0.521B 0.00
RA PHARMCTL INC (RARX) United States $0.515B 0.00
Kezar Life Sciences (KZR) United States $0.513B 0.00
Epizyme (EPZM) United States $0.512B 0.00
Inovio Pharmaceuticals (INO) United States $0.495B 0.00
Osiris Therapeutics (OSIR) United States $0.486B 0.00
BeyondSpring (BYSI) United States $0.478B 0.00
Prothena (PRTA) Ireland $0.464B 0.00
Zymeworks (ZYME) Canada $0.462B 0.00
Senesco Technologies (ELOX) United States $0.459B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.453B 0.00
Anika Therapeutics (ANIK) United States $0.445B 18.42
Replimune (REPL) United States $0.440B 0.00
PDL BioPharma (PDLI) United States $0.436B 7.12
Cytokineticsorporated (CYTK) United States $0.436B 0.00
Five Prime Therapeutics (FPRX) United States $0.427B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.423B 0.00
Kindred Biosciences (KIN) United States $0.420B 0.00
Sinovac Biotech (SVA) China $0.405B 0.00
Zealand Pharma (ZEAL) Denmark $0.392B 4.32
Mesoblast (MESO) Australia $0.388B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.385B 0.00
Abeona Therapeutics (ABEO) United States $0.382B 0.00
Cellular Biomedicine (CBMG) United States $0.373B 0.00
MediciNova (MNOV) United States $0.369B 0.00
ResTORbio (TORC) United States $0.354B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.351B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.345B 0.00
Liquidia Technologies (LQDA) United States $0.343B 0.00
Stemline Therapeutics (STML) United States $0.338B 0.00
Krystal Biotech (KRYS) United States $0.336B 0.00
MeiraGTx Holdings (MGTX) United States $0.331B 0.00
Sorrento Therapeutics (SRNE) United States $0.326B 53.40
Verastem (VSTM) United States $0.322B 0.00
Kodiak Sciences (KOD) United States $0.319B 0.00
Evelo Biosciences (EVLO) United States $0.317B 0.00
Agenus (AGEN) United States $0.314B 0.00
LogicBio Therapeutics (LOGC) United States $0.310B 0.00
Albireo Pharma (ALBO) United States $0.306B 0.00
Athersys (ATHX) United States $0.295B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.285B 0.00
Seres Therapeutics (MCRB) United States $0.283B 0.00
MannKind (MNKD) United States $0.278B 0.00
Syros Pharmaceuticals (SYRS) United States $0.277B 0.00
Magenta Therapeutics (MGTA) United States $0.276B 0.00
Merus (MRUS) Netherlands $0.274B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.271B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.264B 0.00
Geron (GERN) United States $0.261B 0.00
Kadmon Holdings (KDMN) United States $0.257B 0.00
TOCAGEN INC (TOCA) United States $0.256B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.254B 0.00
BioDelivery Sciences (BDSI) United States $0.250B 0.00
Equillium (EQ) United States $0.250B 0.00
Arbutus Biopharma (ABUS) Canada $0.246B 0.00
Intec Pharma (NTEC) Israel $0.246B 0.00
Celcuity (CELC) United States $0.234B 0.00
Adverum Biotechnologies (ADVM) United States $0.232B 0.00
Sutro Biopharma (STRO) United States $0.231B 0.00
Celyad SA (CYAD) Belgium $0.227B 0.00
Aduro Biotech (ADRO) United States $0.222B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.221B 0.00
ADMA Biologics Inc (ADMA) United States $0.221B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.214B 0.00
Strongbridge Biopharma (SBBP) United States $0.213B 0.00
PSivida (EYPT) United States $0.208B 0.00
Urovant Sciences (UROV) United States $0.195B 0.00
Kamada (KMDA) Israel $0.195B 17.96
Aeglea BioTherapeutics (AGLE) United States $0.195B 0.00
Kala Pharmaceuticals (KALA) United States $0.193B 0.00
Synlogic (SYBX) United States $0.187B 0.00
Idera Pharmaceuticals (IDRA) United States $0.184B 0.00
Proteostasis Therapeutics (PTI) United States $0.181B 0.00
Allena Pharmaceuticals (ALNA) United States $0.180B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.178B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.177B 0.00
Unum Therapeutics (UMRX) United States $0.172B 0.00
CorMedix Inc (CRMD) United States $0.169B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.165B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.165B 0.00
BioTime (BTX) United States $0.163B 0.00
Protagonist Therapeutics (PTGX) United States $0.162B 0.00
Compugen (CGEN) Israel $0.162B 0.00
XBiotech (XBIT) United States $0.155B 0.00
Palatin Technologies (PTN) United States $0.154B 19.00
ChromaDex (CDXC) United States $0.154B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.154B 0.00
Axovant Sciences (AXON) United Kingdom $0.152B 0.00
Cohbar (CWBR) United States $0.151B 0.00
Constellation Pharmaceuticals (CNST) United States $0.148B 0.00
Enzo Biochem (ENZ) United States $0.139B 0.00
Cerecor (CERC) United States $0.137B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.136B 0.00
Menlo Therapeutics (MNLO) United States $0.132B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.126B 0.00
Mersana Therapeutics (MRSN) United States $0.124B 0.00
Selecta Biosciences (SELB) United States $0.122B 0.00
XOMA (XOMA) United States $0.122B 0.00
Catalyst Biosciences (CBIO) United States $0.121B 0.00
Pfenex (PFNX) United States $0.120B 0.00
Organovo Holdings (ONVO) United States $0.119B 0.00
Eleven Biotherapeutics (SESN) United States $0.118B 0.00
Spero Therapeutics (SPRO) United States $0.118B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.117B 0.00
NantKwest (NK) United States $0.116B 0.00
Applied Genetic Technologies (AGTC) United States $0.111B 0.00
Pluristem Therapeutics (PSTI) Israel $0.110B 0.00
Cocrystal Pharma (COCP) United States $0.105B 117.33
Sienna Biopharmaceuticals (SNNA) United States $0.104B 0.00
ETON PHARMACEUT (ETON) United States $0.104B 0.00
Axsome Therapeutics (AXSM) United States $0.103B 0.00
TIZIANA LIFE SC (TLSA) United Kingdom $0.103B 0.00
VBI Vaccines (VBIV) United States $0.100B 0.00
Cue Biopharma (CUE) United States $0.097B 0.00
Motif Bio Plc (MTFB) United States $0.097B 0.00
Anavex Life Sciences (AVXL) United States $0.096B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.096B 0.00
Signal Genetics (MGEN) United States $0.096B 0.00
PHASEBIO PHARMA (PHAS) United States $0.095B 0.00
Neothetics (EVFM) United States $0.092B 0.00
Chiasma (CHMA) United States $0.091B 0.00
Cel-Sci (CVM) United States $0.091B 0.00
ScPharmaceuticals (SCPH) United States $0.087B 0.00
Mustang Bio (MBIO) United States $0.087B 0.00
Provention Bio (PRVB) United States $0.086B 0.00
Cidara Therapeutics (CDTX) United States $0.083B 0.00
Aptose Biosciences (APTO) Canada $0.083B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.082B 0.00
Orgenesis (ORGS) United States $0.080B 0.00
OVID THERAPEUTC (OVID) United States $0.079B 0.00
VTv Therapeutics (VTVT) United States $0.077B 0.00
Monster Digital (INNT) United States $0.075B 0.00
VolitionRX (VNRX) Singapore $0.073B 0.00
ITUS (ANIX) United States $0.073B 0.00
Checkpoint Therapeutics (CKPT) United States $0.073B 0.00
BioXcel Therapeutics (BTAI) United States $0.071B 0.00
Alimera Sciences (ALIM) United States $0.069B 0.00
Bellerophon Therapeutics (BLPH) United States $0.067B 0.00
Bionano Genomics (BNGO) United States $0.065B 0.00
NewLink Genetics (NLNK) United States $0.064B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.064B 0.00
Prima BioMed (IMMP) Australia $0.064B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.063B 0.00
Sophiris Bio (SPHS) United States $0.062B 0.00
Ophthotech (OPHT) United States $0.061B 0.00
Protalix BioTherapeutics (PLX) Israel $0.061B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
Evogene (EVGN) Israel $0.060B 0.00
Fortress Biotech (FBIO) United States $0.060B 0.00
Entera Bio (ENTX) Israel $0.056B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.055B 0.00
Alcobra (ARCT) United States $0.055B 0.00
AEterna Zentaris (AEZS) United States $0.054B 10.31
Versartis (ARAV) United States $0.054B 4.73
VistaGen Therapeutics (VTGN) United States $0.053B 0.00
Trevena (TRVN) United States $0.052B 0.00
Arsanis (ASNS) United States $0.051B 0.00
Asterias Biotherapeutics (AST) United States $0.050B 0.00
OncoSec Medical (ONCS) United States $0.049B 0.00
Caladrius Biosciences (CLBS) United States $0.047B 0.00
Leap Therapeutics (LPTX) United States $0.047B 0.00
Aptevo Therapeutics (APVO) United States $0.045B 0.00
Celldex Therapeutics (CLDX) United States $0.045B 0.00
Zosano Pharma (ZSAN) United States $0.044B 0.00
Clearside Biomedical (CLSD) United States $0.044B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Oncobiologics (OTLK) United States $0.042B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.040B 0.00
Moleculin Biotech (MBRX) United States $0.040B 0.00
Eyenovia (EYEN) United States $0.038B 0.00
Galena Biopharma (SLS) United States $0.038B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.037B 5.94
Celsion (CLSN) United States $0.036B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
Proteon Therapeutics (PRTO) United States $0.034B 0.00
TRACON Pharmaceuticals (TCON) United States $0.034B 0.00
AquaBounty Technologies (AQB) United States $0.032B 0.00
Oragenics (OGEN) United States $0.031B 0.00
GTx (GTXI) United States $0.031B 0.00
VIVUS (VVUS) United States $0.030B 0.00
AZURRX BIOPHARM (AZRX) United States $0.029B 0.00
Aileron Therapeutics (ALRN) United States $0.029B 0.00
DiaMedica Therapeutics (DMAC) United States $0.028B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.028B 0.00
Histogenics (HSGX) United States $0.027B 0.00
Vical (VICL) United States $0.027B 0.00
BioPharmX (BPMX) United States $0.026B 0.00
IMMURON LTD (IMRN) Australia $0.026B 0.00
Titan Pharmaceuticals (TTNP) United States $0.021B 0.00
Benitec Biopharma (BNTC) Australia $0.021B 0.00
Cleveland BioLabs (CBLI) United States $0.021B 0.00
Curis (CRIS) United States $0.021B 0.00
Novelion Therapeutics (NVLN) Canada $0.020B 0.00
Advaxis (ADXS) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
GENPREX INC (GNPX) United States $0.018B 0.00
CytRx (CYTR) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
Cellect Biotechnology (APOP) Israel $0.017B 0.00
Therapix Biosciences (TRPX) Israel $0.017B 8.70
ATyr Pharma (LIFE) United States $0.016B 0.00
Soligenix (SNGX) United States $0.016B 0.00
TrovaGene (TROV) United States $0.016B 0.00
Genetic Technologies (GENE) Australia $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.015B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.015B 0.00
Edge Therapeutics (EDGE) United States $0.014B 0.00
Novogen (KZIA) Australia $0.013B 0.00
IBio (IBIO) United States $0.013B 0.00
Adial Pharmaceuticals (ADIL) United States $0.013B 0.00
Prana Biotechnology (PRAN) Australia $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
RestorGenex (DFFN) United States $0.011B 0.00
Vital Therapies (VTL) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
Cerulean Pharma (DARE) United States $0.009B 0.00
Neuralstem (CUR) United States $0.008B 0.00
Aytu Bioscience (AYTU) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.007B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
AmpliPhi Biosciences (APHB) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00